Merck’s $1.9 billion deal for research into anti
Post# of 148643
https://www.fiercebiotech.com/biotech/merck-s...3792801H0W
Quote:
“We look forward to collaborating with the team at Mestag to identify new potential therapeutic options for patients with fibrosis and inflammatory diseases,” Levesque added.